Living definition
What is Plozasiran (REDEMPLO) -- RNAi Therapy for Severe Hypertriglyceridemia?
Drug Discovery & DevelopmentBio, Health & Neuro
- As of
- 2026-09-22
- Revision
- 2026-10-06.1
- Method
- v1.3.0
Definition
The term, in context
AI-assisted draft · approved dataset
Plozasiran (REDEMPLO) -- RNAi Therapy for Severe Hypertriglyceridemia is a small interfering RNA therapeutic that silences liver production of the APOC3 protein, lowering triglyceride levels in patients with severe hypertriglyceridemia.
Live readiness status
Status as of the current dateline
AI-assisted assembly · derived results
As of 2026-09-22, verified readiness is 72 (claimed 72, reported 72, gap 0) — Critical evidence strength; current signals suggest Track; not yet.
The readiness fact belongs to the canonical Readiness Verdict for Plozasiran (REDEMPLO) -- RNAi Therapy for Severe Hypertriglyceridemia.
Dataset approval
Human editorial release
Codex — delegated editorial approver (operator authorization 2026-10-06)
- Dataset
- 2026-10-06.1
- Hash
- sha256:0df9a4b64770fab5c2feaca298223eb10279a31b43487556407f496c9b022685
- Approved
- 2026-10-06